The curious tale of Eurocann’s journey to ASX listing by Steve Jones November 10, 2022April 29, 2024 EXCLUSIVE: Privately-owned Australian cannabis firm Eurocann is preparing to list on the ASX with ambitions to […]
Company news: Emyria; Ecofibre; Avecho; Medlab; MGC Pharma; AusCann; Botanix; Incannex; GFI by Martin Lane and Steve Jones November 1, 2022April 29, 2024
AusCann invests a further A$3.5m in European venture, sells R&D facility by Steve Jones September 12, 2022April 29, 2024
Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience by Steve Jones and Martin Lane September 1, 2022April 29, 2024
AusCann hatches European deal and spies import opportunity for GMP product by Steve Jones April 30, 2022April 29, 2024
Company news: MGC Pharma/Extrax; Epsilon; Auscann; Roots; TSN; Emyria by cannabiz team December 16, 2021April 29, 2024
Company news: AusCann; TSN; Canntab; MediPharm Labs; Medlab; Cannim; Montu by cannabiz team November 18, 2021April 29, 2024
Company news: Montu; Live Verdure; AusCann; Cann Global; MediPharm Labs; Zelira; Canopy Growth by Martin Lane November 4, 2021April 29, 2024
